The project coordinator (ISS) and the partner STAKES contacted the ECHIM project secretariats (KTL and Stakes, Helsinki, Dr Arpo Aromaa; ISS, Rome, Dr Emanuele Scafato). The first deliverable “Survey: result of the first phase”, including the list of the 54 outcome indicators, circulated within the ECHIM network. Later, EUPHORIC was asked to submit a set of indicators to be considered on the ECHI short list. The following four indicators were selected: (AMI case fatality rate (or survival); CABG case fatality rate; revision rate (orthopaedic); revision burden rate (orthopaedic)).
The coordinator of the eHID project, Dr Douglas Fleming, was contacted by the project leader during the 8th HSWP meeting. Reports were exchanged. eHID focuses on information collected by GP for 4 specific indicators: incidence and prevalence of diabetes, burden of mental illness, and the prevalence of ischaemic heart disease. During the 4th EUPHORIC meeting (Helsinki, 9 October 2007) it was agreed that the leader of the cardiovascular pilot would check the usability in the cardiovascular project of the data collected by the eHID project since the analysis refers to British local prevalences.
The leader of the orthopaedic pilot, Dr. Gerold Labek (EAR) contacted EUnetHTA via the beneficiary partners CAHTA (now AQURA) in Barcelona, Spain and a meeting was organized. During the meeting both projects were presented. Taking into account the situation of both projects (EUnetHTA is in its final stage), it was stated that presently it is not possible and reasonable to establish direct cooperation. However, it was agreed that cooperation in potential future projects concerning health technology assessment and market monitoring is recommended. Bilateral information was agreed. The two partners of EUnetHTA (CAHTA, Spain, and LBI-HTA, Austria) were included as collaborating partners of EUPHORIC. Their interests, ongoing activities, and competence are complementary to EUPHORIC and their cooperation will give additional value to the whole EUPHORIC consortium. On 23 January 2008, the link to the EUPHORIC website was added to the HTA Resources web page.
The project leader, Marina Torre contacted Luciano Vittozzi, the project leader of the EUGLOREH project. The aim of this project is to produce a report about health in Europe. Luciano Vittozzi agreed to cooperate with EUPHORIC, therefore, he proposed considering in the EUGLOREH report a focus box dedicated to the outcome research and to EUPHORIC.
Dr Päivi Hämäläinen, Finnish coordinator of the OECD Quality Indicator Project, was invited to the 4th EUPHORIC meeting (Helsinki, 9 October 2007). EUPHORIC will cooperate with the OECD in order to share and mutually disseminate the results in both networks. Partner STAKES will coordinate this activity.
Dr Olli Nylander, Finnish coordinator of the Hospital Data Project, was invited to the 4th EUPHORIC meeting (Helsinki, 9 October 2007). Cooperation with the HDP can be useful in gathering specific information needed by both pilots. Partner DEASL will follow this activity.
European patients’ forum
Targeting citizens and patients is imperative in the context of public health. In regards to this aim, the European Patient’s Forum would be an optimal channel to reach patients and disseminate the results. Together with Nicola Bedlington, EPF Director and Roxana Radulescu of the Value+ project, it was agreed to evaluate the possibility of establishing this kind of cooperation.
The Mattoni project (2004-2007) published its final report in February 2007. During the project, 7 areas were selected and 43 indicators developed. The first list, elaborated by the Mattoni project, was presented by the ISS to the EUPHORIC consortium as a starting basis to develop a final list to be used in a European context. The aim of the Mattoni project was to perform a description of the Italian health system situation by providing benchmarking among regions and hospitals. By using this as a starting point, EUPHORIC expanded it to an international context. Therefore, the methodology developed in the Mattoni project (based on the possibility of using risk adjustment methods) was adopted and adapted by the EUPHORIC project in order to provide a thorough analysis of the different contexts of the participating countries. Moreover, not all the indicators selected by the Mattoni project resulted as useful in achieving the EUPHORIC objectives, since most of them referred to the particular Italian context. Therefore, the proposed list was updated considering both the literature research performed by each partner and their experience in the specific fields. As a result, a long list consisting of 54 outcome indicators in 9 areas of pathology was defined. The results of this first phase of the project (survey) were collected in the deliverable n.1 “Survey: the first phase of the project” (submitted in 2007).
Partner STAKES-CHESS has been coordinating the PERFECT project in Finland (PERFormance, Effectiveness and Cost of Treatment episodes). The project aims at developing methods for register-based measurement of the cost effectiveness of treatment. It also aims to create a comparative database that shows the treatments given and to compare their costs and effectiveness (outcomes) between countries, hospitals, hospital districts, regions and population groups. From the Finnish perspective, the EUPHORIC and PERFECT projects are coordinated so that the Finnish part of the international comparative research for EUPHORIC was done in close cooperation with the PERFECT project. PERFECT is a joint project by the Social Insurance Institution of Finland, STAKES and university hospital districts that covers the period 2004-2007. The project, which is part of the Academy of Finland's Research Programme on Health Services Research, is also funded by the Finnish Funding Agency of Technology and Innovation (FinnWELL - Future Health Care Technology Programme) and SITRA (the Finnish Innovation Fund).
This project was launched in September 2009 to validate the results of the Euphoric cardiovascular pilot study. Funded by the EU Commission under the second Public Health Programme 2008-2013, Eurhobop seeks to provide European hospitals with a validated set of statistical functions to assess their performance in the general management of acute myocardial infarction or unstable angina patients and in the use of the treatments aimed at removing the coronary artery occlusion. Eurhobop is intended to provide the European Community with valid standardized and adjusted benchmarking tools that permit European hospitals to monitor their outcomes in key procedures used in coronary artery disease.